Foamix Announces Additional Positive Topline Results from Third Phase 3 Trial (Study FX2017-22) Evaluating FMX101 Topical Minocycline Foam for Moderate-to-Severe Acne

Stock Information for Foamix Pharmaceuticals Ltd.

Loading

Please wait while we load your information from QuoteMedia.